Digital
Generative AI in pharma: Moving beyond hype and into widespread adoption
Generative AI (GenAI) has rapidly pushed its way to the forefront of …
20092 items found
R&D
Where do we stand with clinical trial digitalisation?
Digitalisation is happening all around us, including in tech-enabled …
News
Daiichi and AZ pull Dato-DXd filing in Europe too
AstraZeneca and Daiichi Sankyo confirmed today that they have decided …
News
FDA approves flurry of drugs ahead of holiday season
The FDA has followed its usual procedure of wrapping up a series of …
Oncology
Transforming autoimmune disease therapy: Post-ACR 2024 perspectives on cell therapies
The 2024 American College of Rheumatology (ACR) annual meeting …
News
AZ gets EU okay for Tagrisso in early-stage lung cancer
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in …
News
Sanofi takes SK Bio-partnered pneumococcal shot into phase 3
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a …
R&D
Quality compliance in the digital era
Quality compliance in the pharma industry is foundational to …
News
PBM reform dropped in Congress' funding package
Proposed reforms to the regulations for pharmacy benefit managers …
News
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's olezarsen has become the first FDA-approved drug …
News
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Eli Lilly's Zepbound has become the first drug to be FDA-approved for …
News
Novo Nordisk sheds billions in value on obesity data
Less-than-stellar phase 3 results with Novo Nordisk's highly …
News
Patient organisations 'too influenced by corporate funders'
Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on pharma funding.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
